Results 61 to 70 of about 2,335,195 (317)

A genome-wide association study identifies a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension in the Japanese population

Scientific Reports, 2021
Numerous genetic variants associated with hypertension and blood pressure are known, but there is a paucity of evidence from genetic studies of resistant hypertension, especially in Asian populations.
Yasuo Takahashi, Keiko Yamazaki, Yoichiro Kamatani, Michiaki Kubo, Koichi Matsuda, Satoshi Asai   +5 more
doaj   +1 more source

Comparison of Pregnancy Outcomes of Women with and Without Hypertension at the Latent Phase of Labor Who Were Under Medical Care for Preeclampsia

Gynecology Obstetrics & Reproductive Medicine, 2022
OBJECTIVE: We explored the association between hypertension (>140/90) at the latent phase of labor (resistant hypertension) and the subsequent development of major maternal complications or adverse infant outcomes in women with preeclampsia under ...
Resul Karakus, Cetin Kilicci, Enis Ozkaya, Ezgi Darici, Onder Tosun, Sultan Seren Karakus, Ali Aras   +6 more
doaj   +1 more source

Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials [PDF]

, 2015
Background: To analyze the efficacy and toxicity of bevacizumab on survival outcomes in recurrent ovarian cancer. Results: Bevacizumab was associated with significant improvement of PFS and OS compared with standard treatment with HRs of 0.53 (95% CI 0.
BENEDETTI PANICI, PIERLUIGI, DE FELICE, FRANCESCA, DI DONATO, VIOLANTE, GASPARRI, MARIALUISA, Marchetti, C, MUSELLA, ANGELA, Musio, D, MUZII, LUDOVICO, PALAIA, INNOCENZA, TOMBOLINI, Vincenzo   +9 more
core   +1 more source

Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies. [PDF]

, 2014
Hypertension after treatment with vascular endothelial growth factor (VEGF) receptor inhibitors is associated with superior treatment outcomes for advanced cancer patients.
Bakris, GL, Cohen, EEW, Fleming, GF, House, LK, Karovic, S, Karrison, TG, Levine, MR, Maitland, ML, Ratain, MJ, Rudek, MA, Thomeas, V, Wen, Y, Wright, JJ, Wu, K   +13 more
core   +2 more sources

White-Coat Resistant Hypertension [PDF]

American Journal of Hypertension, 1997
The aim of this study was to evaluate whether sustained hypertensives with high clinic blood pressure, despite multiple drug treatment, show a true resistant hypertension or a "white-coat effect," and whether the pretreatment white-coat effect is maintained despite pharmacological therapy.
MEZZETTI, Andrea, PIERDOMENICO, Sante Donato, Costantini, F, Romano, F, BUCCI, Anna, DI GIOACCHINO, Mario, CUCCURULLO, Franco   +6 more
openaire   +3 more sources

Diagnosis and management of resistant hypertension

British medical journal
Resistant hypertension is defined as blood pressure that remains above the therapeutic goal despite concurrent use of at least three antihypertensive agents of different classes, including a diuretic, with all agents administered at maximum or maximally ...
Ernesto L. Schiffrin, Naomi D L Fisher
semanticscholar   +1 more source

Genome-wide study of resistant hypertension identified from electronic health records.

PLoS ONE, 2017
Resistant hypertension is defined as high blood pressure that remains above treatment goals in spite of the concurrent use of three antihypertensive agents from different classes.
Logan Dumitrescu, Marylyn D Ritchie, Joshua C Denny, Nihal M El Rouby, Caitrin W McDonough, Yuki Bradford, Andrea H Ramirez, Suzette J Bielinski, Melissa A Basford, High Seng Chai, Peggy Peissig, David Carrell, Jyotishman Pathak, Luke V Rasmussen, Xiaoming Wang, Jennifer A Pacheco, Abel N Kho, M Geoffrey Hayes, Martha Matsumoto, Maureen E Smith, Rongling Li, Rhonda M Cooper-DeHoff, Iftikhar J Kullo, Christopher G Chute, Rex L Chisholm, Gail P Jarvik, Eric B Larson, David Carey, Catherine A McCarty, Marc S Williams, Dan M Roden, Erwin Bottinger, Julie A Johnson, Mariza de Andrade, Dana C Crawford   +34 more
doaj   +1 more source

Resistant Hypertension: Disease Burden and Emerging Treatment Options

Current Hypertension Reports
To define resistant hypertension (RHT), review its pathophysiology and disease burden, identify barriers to effective hypertension management, and to highlight emerging treatment options.
J. Flack, Michael G Buhnerkempe, K. T. Moore   +2 more
semanticscholar   +1 more source

Analysis of the application of additional correction methods of insufficient adherence to treatment in patients with resistant and pseudo-resistant arterial hypertension

Journal of Education, Health and Sport, 2017
The article considers the results of the use of home blood pressure monitoring and telephone consultations (visits) on the background of the optimization of antihypertensive therapy in patients with resistant and pseudo-resistant arterial hypertension.
V. Zbitnieva
doaj   +3 more sources

Controlling resistant hypertension [PDF]

The Biomedical & Life Sciences Collection, 2017
Resistant hypertension (failure to achieve target blood pressures with three or more antihypertensive drugs including a diuretic) is an important and preventable cause of stroke. Hypertension is highly prevalent in China (>60% of persons above age 65), and only ~6% of hypertensives in China are controlled to target levels.
openaire   +4 more sources